Single Cell Foundation Model enabled drug discovery for clonal hematopoiesis
- Institution
- Vanderbilt University Medical Center, TN
- Principal investigator
- Alexander Bick
- Funding
- $1.0M
- Duration
- 2025–2027
Moonbase score
Still being scored
Abstract
Project Summary Aging is associated with increased mortality and the prevalence of diseases such as cancer, cardiovascular, neurological, and respiratory diseases. One fundamental mechanism of aging is acquiring DNA mutations, which can lead to clonal hematopoiesis of indeterminate potential (CHIP), frequently driven by mutations in in DNMT3A, TET2, and ASXL 1. We seek to identify and re purpose existing medications or investigational therapeutics to decrease or eliminate the CHIP clone as a way to address multiple agingrelated diseases. We will leverage single cell machine learning foundation models, human genetics, and electronic health records (EHR). We propose a two-phase approach: In the UG3 phase, we will utilize single cell foundation models to perform virtual screens as well as genetic and EHR data to identify existing medications to reverse CHIP pathology. In the UH3 phase, we will experimentally validate drug candidates in in vitro and in vivo CHIP models. Successful execution of this work will rapidly translate findings into the clinic by repurposing FDA-approved medications to mitigate CHIP and its related aging diseases.
Research team
- Alexander BickPI
- Ravi Kiran MadduriPI
- Michael R SavonaPI
LOADING MOONBASE SCORE
Questions for Vanderbilt University Medical Center
Answered by the team behind this research.
No questions yet. Sign in to ask the first one
Related grants
Same researchers, same institution, same topic, scored first.
- NIH · Vanderbilt University Medical CenterNot yet scored
Clonal Hematopoiesis Aging Resiliency Mechanisms
Alexander Bick · $1.3M · 2024–2029
- NIH · Vanderbilt University Medical CenterNot yet scored
Clonal hematopoiesis and inherited genetic variation in sickle cell disease
Alexander Bick · $780K · 2023–2027
- NIH · Vanderbilt University Medical CenterNot yet scored
Establishing the dynamics of lymphoid clonal hematopoiesis and its aging-related disease consequences
Paul L. Auer · $682K · 2023–2028